Clinical Trials Logo
  1. Home
  2. Eczema
  3. NCT03026946

Alitretinoin vs Cyclosporine in Severe Recurrent Vesicular Hand Eczema — ALICsA  

Hand Eczema Clinical Trial

Official title:
Efficacy of Oral Alitretinoin Versus Oral Cyclosporine in Patients With Severe Recurrent Vesicular Hand Eczema. A Randomized Prospective Open-label Trial With Blinded Outcome Assessment

Clinical Trial Summary

The purpose of this study is to compare the efficacy of alitretinoin and cyclosporine in the treatment of patients with severe recurrent vesicular hand eczema.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03026946
Study type Interventional
Source University Medical Center Groningen
Contact MLA Schuttelaar, MD, PhD
Phone +31503612520
Email m.l.a.schuttelaar@umcg.nl
Status Recruiting
Phase Phase 3
Start date May 29, 2017
Completion date July 2022
View Details
See also
  Status Clinical Trial Phase
Completed NCT00576550 - A Randomised Trial of a Moisturising Cream in Preventing Recurrence of Hand Eczema Phase 4
Completed NCT00404196 - LEO19123 Cream in the Treatment of Hand Eczema Phase 2
Completed NCT05763914 - A 24-week Single-blind Trial of Prevention of Hand Eczema in Cleaners N/A
Recruiting NCT03026907 - Alitretinoin vs Azathioprine in Severe Non-hyperkeratotic Hand Eczema Phase 3
Completed NCT00488241 - Multicenter Clinical Study to Examine the Efficacy and Safety of Zarzenda in Patients With Hand Eczema Phase 4
Active, not recruiting NCT05906628 - Topical Ruxolitinib Evaluation in Chronic Hand Eczema Phase 2
Terminated NCT01826630 - A Study to Assess CLn® BodyWash for Reducing Skin Fauna in Patients With Hand Eczema N/A
Recruiting NCT04449575 - Hand Eczema in the Health Care Sector
Withdrawn NCT05219864 - Topical Ruxolitinib Evaluation in Chronic Hand Eczema Study 1 Phase 3
Completed NCT01591785 - Treatment of Staphylococcus Aureus Colonization in Hand Eczema N/A
Completed NCT00826592 - Comparison of Video-Based Versus Written Patient Education on Atopic Dermatitis N/A
Completed NCT02664805 - Proof of Concept, Twice Daily Applications of LEO 124249 Ointment in the Treatment of Chronic Hand Eczema Phase 2
Completed NCT05471934 - Satisfaction Survey - Cicaplast Mains
Active, not recruiting NCT04512339 - Dupilumab in Severe Chronic Hand Eczema Phase 2
Completed NCT04375410 - Consequences of Intensified Handwash and Hand Disinfection Among Children During the COVID19 Pandemic